Secondly, the translation of these findings to other cancer types may be limited to certain cancer cell type as E-cadherin promoter hypermethylation could be the main mechanism for E-cadherin downregulation in other metastatic cancer cells such as breast cancer [37]. Here, CDH1 is linked to breast cancer.